You are here

  • Home
  • Archive
  • Volume 81, Issue 12
  • Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases

Article info

Article menu

Download PDFPDF

Correspondence
Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases
Free

Authors

  • Ryu Watanabe Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan Department of Advanced Medicine for Rheumatic Disease, Kyoto University Graduate School of Medicine, Kyoto, Japan PubMed articlesGoogle scholar articles
  • Motomu Hashimoto Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan Department of Advanced Medicine for Rheumatic Disease, Kyoto University Graduate School of Medicine, Kyoto, Japan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ryu Watanabe, Department of Rheumatology, Osaki Citizen Hospital, Osaki 989-6136, Japan; ryuwatanabe{at}kuhp.kyoto-u.ac.jp
View Full Text

Citation

Watanabe R, Hashimoto M
Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases
Annals of the Rheumatic Diseases 2022;81:e262.

Publication history

  • Received May 15, 2020
  • Accepted May 15, 2020
  • First published August 7, 2020.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.